JUN ZHI Biomedical Co., Ltd. is a biotechnology team from Taiwan, and we have established research and development centers and Operations Center in National Biotechnology Research Park and Tainan Science Park respectively. We have obtained technologies through technology transfer from multiple academic and research institutions. After many years of research and development, we developed the cancer screening service targeted on cancer of digestive system.

The technology of SAA MS screening and interpretation of MS spectra come from academic and research institutions. NTHU is responsible for the development of Magnetic Nanoparticles and antibody for extraction and purification of SAA. NYMU and Metal Industries Research & Development Centre help develop the bio-algorithms, making it more accurate. Last but not least, KMU work on clinical trials and the integration of clinical information to ensurethat SAA nano MS screening service has high accuracy and also help practically in the medical field.